Can New Drugs Drive J&J's Innovative Medicine Despite Stelara LOE? Mar 31, 2026 · JNJ's Innovative Medicine unit eyes Q1 growth on key drug momentum, but biosimilar pressure and Stelara's decline may weigh on results. Read more »